PRESS RELEASE published on 10/23/2024 at 18:30, 28 days 19 hours ago Quarterly financial reporting / Third quarter financial report Clariane reports 6.3% organic revenue growth for the first nine months of 2024, confirming 2024 guidance of over 5% growth. Progress on €1bn disposal plan Revenue Growth Organic Growth 2024 Guidance Clariane Disposal Plan
PRESS RELEASE published on 10/08/2024 at 23:24, 1 month 12 days ago Half yearly financial reports and audit reports/limited reviews / Half yearly financial report
BRIEF published on 09/25/2024 at 09:38, 1 month 26 days ago Crossing thresholds at CLARIANE Convertible Bonds Morgan Stanley Acquisition Of Shares Crossing Thresholds Clariane
BRIEF published on 09/24/2024 at 09:05, 1 month 27 days ago Crossing of thresholds by Morgan Stanley at CLARIANE Voting Rights Capital Morgan Stanley Crossing Thresholds Clariane
BRIEF published on 09/20/2024 at 21:10, 2 months ago Clariane joins the CAC SBT 1.5° index Sustainability Carbon Footprint Clariane CAC SBT 1.5° Stock Index
PRESS RELEASE published on 09/20/2024 at 21:05, 2 months ago Inside Information / Other news releases Clariane integrates into the CAC SBT 1.5° to reduce carbon footprint, aligning with its purpose-driven commitments. Entry effective from September 23, 2024 Carbon Footprint Clariane Commitments CAC SBT 1.5° Purpose-driven
BRIEF published on 09/16/2024 at 20:03, 2 months 4 days ago Reorganization within the Clariane Group Operational Excellence Appointments Reorganization Direction Clariane
PRESS RELEASE published on 09/16/2024 at 19:58, 2 months 4 days ago Inside Information / Other news releases Clariane Group announces appointments to enhance operational excellence and performance. New Deputy CEO and Executive Vice President, Group CFO, and Group General Secretary appointed Operational Excellence Appointments Performance Management Clariane Group
BRIEF published on 09/13/2024 at 08:05, 2 months 8 days ago Clariane joins the SBF 120 index SBF 120 Financial Growth Clariane Paris Stock Exchange Mission-driven Company
BRIEF published on 08/05/2024 at 18:54, 3 months 15 days ago Sophie Boissard renewed as Managing Director of the Clariane Group Renewal Leadership Management Health Clariane
Published on 11/21/2024 at 13:30, 23 minutes ago AirIQ Announces September 30, 2024 Quarterly Results Company Reports Double-Digit Growth in Recurring Revenue
Published on 11/21/2024 at 13:30, 23 minutes ago Datametrex Secures Additional P.O. Approx $250K for IT Services
Published on 11/21/2024 at 13:00, 53 minutes ago Aclara Secures Funding from Corfo's Innovation High-Tech Program for Artificial Intelligence Project
Published on 11/21/2024 at 13:00, 53 minutes ago Telomir Pharmaceuticals Confirms Age Reversal, Increased Longevity and Improved Healthspan in Groundbreaking Preclinical Study with Telomir-1
Published on 11/21/2024 at 13:00, 53 minutes ago Toggle3D.ai Rebrands as FOTOgpt.ai to Usher in a New Age of AI-Powered Photography
Published on 11/21/2024 at 12:35, 1 hour 17 minutes ago audius with successful third quarter 2024 - total revenue grows by +9.2% and EBITDA by +14.6
Published on 11/21/2024 at 12:15, 1 hour 38 minutes ago Hardman & Co Investor Forum Research on Shield Therapeutics (STX): Proactive cash management to cashflow-breakeven
Published on 11/21/2024 at 06:58, 6 hours 55 minutes ago Net Asset Value per share increases with 9.4% in six months to EUR 55.6 thanks to continued strong growth performance of the portfolio
Published on 11/20/2024 at 19:20, 18 hours 33 minutes ago Peugeot Invest Board of Directors to evolve following the May 2025 Annual General Meeting
Published on 11/20/2024 at 17:45, 20 hours 8 minutes ago MEDESIS PHARMA HAS COMPLETED ITS CLINICAL STUDY FOR THE TREATMENT OF ALZHEIMER'S DISEASE WITH NANOLITHIUM
Published on 11/20/2024 at 17:45, 20 hours 8 minutes ago Disclosure of Share Capital and Voting Rights Outstanding as of October 31, 2024
Published on 11/20/2024 at 07:45, 1 day 6 hours ago Gimv sells to Fremman Capital a majority stake in outpatient rehabilitation specialist rehaneo
